HIV-AIDS Testing Market Size, Share, Trends, Growth Outlook

HIV-AIDS Testing Market is estimated to increase at a growth rate of 10.5% CAGR over the forecast period from 2024 to 2030.

The global HIV-AIDS Testing Market Study analyzes and forecasts the market size across 6 regions and 24 countries for diverse segments including By Product (Consumables, Instruments, Software and Services), By Test (Antibody Tests, Viral Load Tests, CD4 Tests, Tests for Early Infant Diagnosis, Tests for Viral Identification), By End-User (Diagnostic Laboratories, Hospitals, Blood Banks, Home Care Settings, Others).

An Introduction to HIV-AIDS Testing Market in 2024

The HIV-AIDS Testing Market encompasses diagnostic tests, screening assays, and monitoring tools used for the detection of human immunodeficiency virus (HIV) infection, staging of acquired immunodeficiency syndrome (AIDS), and monitoring of viral load in HIV-positive individuals. This market includes rapid tests, enzyme-linked immunosorbent assays (ELISA), nucleic acid tests (NAT), and point-of-care (POC) devices designed for accurate, timely, and accessible HIV testing. Innovations in HIV-AIDS testing focus on improved sensitivity, specificity, and usability of diagnostic assays to facilitate early diagnosis, treatment initiation, and disease management strategies.

HIV-AIDS Testing Market Competitive Landscape

The global HIV-AIDS Testing Industry is highly competitive with a large number of companies focusing on niche market segments. Amidst intense competitive conditions, HIV-AIDS Testing Companies are investing in new product launches and strengthening distribution channels. Key companies operating in the HIV-AIDS Testing Industry include- Abbott Laboratories, AbbVie Inc, Alere Inc, BD Biosciences, Beckman Coulter, Brsitol-Myers Squibb, Gilead Sciences, Janssen Therapeutics, Merck and Co. Inc, VIIV Healthcare.

HIV AIDS Testing Market Trend: Expansion of Point-of-Care Testing

A significant trend in the HIV AIDS Testing market is the expansion of point-of-care testing (POCT) for HIV diagnosis and monitoring, driven by the need for rapid and decentralized screening solutions. POCT devices enable healthcare providers to perform HIV testing at the point of care, such as community health centers, clinics, and outreach settings, without the need for laboratory infrastructure or specialized training. The adoption of POCT for HIV testing facilitates early diagnosis, linkage to care, and timely initiation of antiretroviral therapy (ART), contributing to improved clinical outcomes and reduced transmission rates. This trend reflects efforts to overcome barriers to HIV testing access and uptake, particularly in resource-limited settings, and supports global initiatives towards ending the HIV/AIDS epidemic by 2030.

HIV AIDS Testing Market Driver: Focus on HIV Prevention and Treatment

The primary driver for the HIV AIDS Testing market is the global focus on HIV prevention, treatment, and care, underpinned by efforts to achieve the United Nations' Sustainable Development Goal of ending the AIDS epidemic by 2030. HIV testing plays a critical role in the HIV care continuum, enabling early detection of infection, timely initiation of treatment, and prevention of onward transmission. The scale-up of HIV testing services, including routine screening, targeted testing strategies, and self-testing initiatives, aims to reach key populations at higher risk of HIV acquisition and transmission, such as men who have sex with men (MSM), transgender individuals, sex workers, and people who inject drugs (PWID). The increasing emphasis on HIV testing as a cornerstone of HIV prevention and treatment efforts drives market growth and innovation in HIV testing technologies and strategies.

HIV AIDS Testing Market Opportunity: Integration of Novel Testing Technologies

An emerging opportunity in the HIV AIDS Testing market lies in the integration of novel testing technologies, such as molecular diagnostics, rapid antigen/antibody assays, and point-of-care nucleic acid amplification tests (NAATs), to enhance the accuracy, accessibility, and efficiency of HIV testing services. Molecular diagnostic platforms, such as PCR-based assays and next-generation sequencing (NGS), offer improved sensitivity and specificity for HIV detection and drug resistance testing, particularly in early and acute infection settings. Rapid antigen/antibody assays provide rapid results within minutes, enabling same-day diagnosis and immediate linkage to care. Point-of-care NAATs offer the convenience of rapid testing with laboratory-grade performance, facilitating HIV testing in remote or resource-limited settings. Collaborative efforts between diagnostic companies, public health agencies, and advocacy organizations could drive the development and adoption of innovative HIV testing technologies, expanding access to HIV testing services and advancing progress towards global HIV/AIDS goals.

HIV AIDS Testing Market Share Analysis: Tests for Early Infant Diagnosis is the fastest growing market segment over the forecast period to 2030

Tests for early infant diagnosis are experiencing significant growth in the realm of HIV AIDS testing. This growth is primarily due to increasing efforts to prevent mother-to-child transmission of HIV and improve early detection and treatment of HIV-infected infants. Early diagnosis of HIV in infants is crucial for initiating timely antiretroviral therapy, which can significantly improve their chances of survival and long-term health outcomes. These tests typically involve molecular techniques such as PCR (polymerase chain reaction) assays to detect HIV DNA or RNA in blood samples obtained from newborns. With the global scale-up of prevention of mother-to-child transmission programs and the increasing availability of point-of-care testing in resource-limited settings, there is a growing demand for accurate and accessible tests for early infant diagnosis of HIV. Moreover, advancements in technology and the development of novel testing platforms are further driving growth in this segment, underscoring its importance in pediatric HIV care and management.

HIV-AIDS Testing Market Segmentation

By Product
Consumables
Instruments
Software and Services
By Test
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
By End-User
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Others
Geographical Analysis
North America (United States, Canada, Mexico)
Europe (Germany, France, United Kingdom, Spain, Italy, Rest of Europe)
Asia Pacific (China, India, Japan, South Korea, Rest of Asia Pacific)
South America (Brazil, Argentina, Rest of South America)
Middle East and Africa (Saudi Arabia, UAE, Rest of Middle East, South Africa, Egypt, Rest of Africa)

HIV-AIDS Testing Companies

Abbott Laboratories
AbbVie Inc
Alere Inc
BD Biosciences
Beckman Coulter
Brsitol-Myers Squibb
Gilead Sciences
Janssen Therapeutics
Merck and Co. Inc
VIIV Healthcare
* List not Exhaustive

Reasons to Buy the HIV-AIDS Testing Market Study

• Deepen your industry insights and navigate uncertainties for strategy formulation, CAPEX, and Operational decisions
• Gain access to detailed insights on the HIV-AIDS Testing Market, encompassing current market size, growth trends, and forecasts till 2030.
• Access detailed competitor analysis, enabling competitive advantage through a thorough understanding of market players, strategies, and potential differentiation opportunities
• Stay ahead of the curve with insights on technological advancements, innovations, and upcoming trends
• Identify lucrative investment avenues and expansion opportunities within the HIV-AIDS Testing Industry, guided by robust, data-backed analysis.
• Understand regional and global markets through country-wise analysis, regional market potential, regulatory nuances, and dynamics
• Execute strategies with confidence and speed through information, analytics, and insights on the industry value chain
• Corporate leaders, strategists, financial experts, shareholders, asset managers, and governmental representatives can make long-term planning scenarios and build an integrated and timely understanding of market dynamics
• Benefit from tailored solutions and expert consultation based on report insights, providing personalized strategies aligned with specific business needs.

TABLE OF CONTENTS

1 Introduction to 2024 HIV-AIDS Testing Market
1.1 Market Overview
1.2 Quick Facts
1.3 Scope/Objective of the Study
1.4 Market Definition
1.5 Countries and Regions Analyzed
1.6 Units, Currency, and Conversions
1.7 Industry Value Chain

2 Research Methodology
2.1 Market Size Estimation
2.2 Sources and Research Methodology
2.3 Data Triangulation
2.4 Assumptions and Limitations

3 Executive Summary
3.1 Global HIV-AIDS Testing Market Size Outlook, $ Million, 2021 to 2030
3.2 HIV-AIDS Testing Market Outlook by Type, $ Million, 2021 to 2030
3.3 HIV-AIDS Testing Market Outlook by Product, $ Million, 2021 to 2030
3.4 HIV-AIDS Testing Market Outlook by Application, $ Million, 2021 to 2030
3.5 HIV-AIDS Testing Market Outlook by Key Countries, $ Million, 2021 to 2030

4 Market Dynamics
4.1 Key Driving Forces of HIV-AIDS Testing Industry
4.2 Key Market Trends in HIV-AIDS Testing Industry
4.3 Potential Opportunities in HIV-AIDS Testing Industry
4.4 Key Challenges in HIV-AIDS Testing Industry

5 Market Factor Analysis
5.1 Value Chain Analysis
5.2 Competitive Landscape
5.2.1 Global HIV-AIDS Testing Market Share by Company (%), 2023
5.2.2 Product Offerings by Company
5.3 Porter’s Five Forces Analysis
5.4 Pricing Analysis and Outlook

6 Growth Outlook Across Scenarios
6.1 Growth Analysis-Case Scenario Definitions
6.2 Low Growth Scenario Forecasts
6.3 Reference Growth Scenario Forecasts
6.4 High Growth Scenario Forecasts

7 Global HIV-AIDS Testing Market Outlook by Segments
7.1 HIV-AIDS Testing Market Outlook by Segments, $ Million, 2021- 2030
By Product
Consumables
Instruments
Software and Services
By Test
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
By End-User
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Others
8 North America HIV-AIDS Testing Market Analysis and Outlook To 2030
8.1 Introduction to North America HIV-AIDS Testing Markets in 2024
8.2 North America HIV-AIDS Testing Market Size Outlook by Country, 2021-2030
8.2.1 United States
8.2.2 Canada
8.2.3 Mexico
8.3 North America HIV-AIDS Testing Market size Outlook by Segments, 2021-2030
By Product
Consumables
Instruments
Software and Services
By Test
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
By End-User
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Others
9 Europe HIV-AIDS Testing Market Analysis and Outlook To 2030
9.1 Introduction to Europe HIV-AIDS Testing Markets in 2024
9.2 Europe HIV-AIDS Testing Market Size Outlook by Country, 2021-2030
9.2.1 Germany
9.2.2 France
9.2.3 Spain
9.2.4 United Kingdom
9.2.4 Italy
9.2.5 Russia
9.2.6 Norway
9.2.7 Rest of Europe
9.3 Europe HIV-AIDS Testing Market Size Outlook by Segments, 2021-2030
By Product
Consumables
Instruments
Software and Services
By Test
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
By End-User
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Others
10 Asia Pacific HIV-AIDS Testing Market Analysis and Outlook To 2030
10.1 Introduction to Asia Pacific HIV-AIDS Testing Markets in 2024
10.2 Asia Pacific HIV-AIDS Testing Market Size Outlook by Country, 2021-2030
10.2.1 China
10.2.2 India
10.2.3 Japan
10.2.4 South Korea
10.2.5 Indonesia
10.2.6 Malaysia
10.2.7 Australia
10.2.8 Rest of Asia Pacific
10.3 Asia Pacific HIV-AIDS Testing Market size Outlook by Segments, 2021-2030
By Product
Consumables
Instruments
Software and Services
By Test
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
By End-User
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Others
11 South America HIV-AIDS Testing Market Analysis and Outlook To 2030
11.1 Introduction to South America HIV-AIDS Testing Markets in 2024
11.2 South America HIV-AIDS Testing Market Size Outlook by Country, 2021-2030
11.2.1 Brazil
11.2.2 Argentina
11.2.3 Rest of South America
11.3 South America HIV-AIDS Testing Market size Outlook by Segments, 2021-2030
By Product
Consumables
Instruments
Software and Services
By Test
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
By End-User
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Others
12 Middle East and Africa HIV-AIDS Testing Market Analysis and Outlook To 2030
12.1 Introduction to Middle East and Africa HIV-AIDS Testing Markets in 2024
12.2 Middle East and Africa HIV-AIDS Testing Market Size Outlook by Country, 2021-2030
12.2.1 Saudi Arabia
12.2.2 UAE
12.2.3 Oman
12.2.4 Rest of Middle East
12.2.5 Egypt
12.2.6 Nigeria
12.2.7 South Africa
12.2.8 Rest of Africa
12.3 Middle East and Africa HIV-AIDS Testing Market size Outlook by Segments, 2021-2030
By Product
Consumables
Instruments
Software and Services
By Test
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
By End-User
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Others
13 Company Profiles
13.1 Company Snapshot
13.2 SWOT Profiles
13.3 Products and Services
13.4 Recent Developments
13.5 Financial Profile
List of Companies
Abbott Laboratories
AbbVie Inc
Alere Inc
BD Biosciences
Beckman Coulter
Brsitol-Myers Squibb
Gilead Sciences
Janssen Therapeutics
Merck and Co. Inc
VIIV Healthcare
14 Appendix
14.1 Customization Offerings
14.2 Subscription Services
14.3 Related Reports
14.4 Publisher Expertise

By Product
Consumables
Instruments
Software and Services
By Test
Antibody Tests
Viral Load Tests
CD4 Tests
Tests for Early Infant Diagnosis
Tests for Viral Identification
By End-User
Diagnostic Laboratories
Hospitals
Blood Banks
Home Care Settings
Others